| Dr Nydia I Sepulveda-pagan Ii, MD | |
|
Carr 135 Km 70.2, Bo. Yahuecas, Adjuntas, PR 00601-9711 | |
| (787) 829-0824 | |
| (787) 597-6372 |
| Full Name | Dr Nydia I Sepulveda-pagan Ii |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | Carr 135 Km 70.2, Adjuntas, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376504993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 15427 (Puerto Rico) | Primary |
| Entity Name | Corporacion Servicios Medicos Primarios Y Prevencion De Hatillo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306877279 PECOS PAC ID: 6204014913 Enrollment ID: O20110629000016 |
News Archive
People with severe injuries to their spinal cord currently have no prospect of recovery and remain confined to their wheelchairs. Now, all that could change with a new treatment that stimulates the spinal cord using electric impulses.
Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.
Research looking at genomic data from women with a genetic risk for breast cancer, who may never develop cancer, found their cancer-free state may be related to a second genetic variation.
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nydia I Sepulveda-pagan Ii, MD Carr. 135 Km. 70.2, Bo. Yahuecas, Adjuntas, PR 00601-9711 Ph: (787) 829-0824 | Dr Nydia I Sepulveda-pagan Ii, MD Carr 135 Km 70.2, Bo. Yahuecas, Adjuntas, PR 00601-9711 Ph: (787) 829-0824 |
News Archive
People with severe injuries to their spinal cord currently have no prospect of recovery and remain confined to their wheelchairs. Now, all that could change with a new treatment that stimulates the spinal cord using electric impulses.
Ameritox, a national leader in medication monitoring solutions for patients prescribed opioids and other medications for chronic pain and severe mental illness, today applauded the declaration of the opioid crisis as a national public health emergency by President Donald J. Trump.
Research looking at genomic data from women with a genetic risk for breast cancer, who may never develop cancer, found their cancer-free state may be related to a second genetic variation.
Trius Therapeutics, Inc., a biopharmaceutical company developing innovative antibiotics for serious, life-threatening infections, announced today the initial public offering of 10,000,000 shares of its common stock at a price of $5.00 per share. The common stock is expected to begin trading on the NASDAQ Global Market on August 3, 2010 under the trading symbol "TSRX." Trius has granted the underwriters a 45 day option to purchase up to 750,000 shares of its common stock at the initial public offering price to cover over-allotments, if any.
› Verified 2 days ago
Francisco Manuel Murphy-rivera, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19 Calle San Joaquin, Adjuntas, PR 00601 Phone: 787-829-4596 Fax: 787-829-4571 |